Canada - English - Health Canada

biologische heilmittel heel gmbh - melissa officinalis - liquid - 10d - melissa officinalis 10d - homeopathic products

Canada - English - Health Canada

biologische heilmittel heel gmbh - melissa officinalis - liquid - 4d - melissa officinalis 4d - homeopathic products

United States - English - NLM (National Library of Medicine)

uriel pharmacy inc. - melissa officinalis (unii: yf70189l0n) (melissa officinalis - unii:yf70189l0n) - melissa officinalis 1 [hp_x] in 1 g - directions: for topical use only. use: temporary relief of cold sores.

Canada - English - Health Canada

dolisos laboratoires s.a. - melissa officinalis - drops - 1dh - melissa officinalis 1dh - homeopathic products

Canada - English - Health Canada

weleda ag heilmittelbetriebe - melissa officinalis - drops - 2d - melissa officinalis 2d - homeopathic products

Canada - English - Health Canada

dolisos canada inc. - melissa officinalis - globules - 1x - melissa officinalis 1x - homeopathic products

New Zealand - English - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - fentanyl 16.8mg;   - transdermal patch - 100 mcg/h - active: fentanyl 16.8mg   excipient: durotak 87-4287 pegoterate   - the management of chronic cancer pain. the management of opioid-responsive chronic severe pain of non-malignant origin in opioid tolerant patients, after other conservative methods of analgesia have been tried. for use in accordance with nzma guidelines on chronic pain management and where there is no psychological contraindication, drug seeking behaviour or history of drug misuse.

New Zealand - English - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - fentanyl 2.1mg;   - transdermal patch - 12 mcg/h - active: fentanyl 2.1mg   excipient: durotak 87-4287 pegoterate   - the management of chronic cancer pain. the management of opioid-responsive chronic severe pain of non-malignant origin in opioid tolerant patients, after other conservative methods of analgesia have been tried. for use in accordance with nzma guidelines on chronic pain management and where there is no psychological contraindication, drug seeking behaviour or history of drug misuse.

New Zealand - English - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - fentanyl 4.2mg;   - transdermal patch - 25 mcg/h - active: fentanyl 4.2mg   excipient: durotak 87-4287 pegoterate   - the management of chronic cancer pain. the management of opioid-responsive chronic severe pain of non-malignant origin in opioid tolerant patients, after other conservative methods of analgesia have been tried. for use in accordance with nzma guidelines on chronic pain management and where there is no psychological contraindication, drug seeking behaviour or history of drug misuse.

New Zealand - English - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - fentanyl 6.3mg;   - transdermal patch - 37 mcg/h - active: fentanyl 6.3mg   excipient: durotak 87-4287 pegoterate   - the management of chronic cancer pain. the management of opioid-responsive chronic severe pain of non-malignant origin in opioid tolerant patients, after other conservative methods of analgesia have been tried. for use in accordance with nzma guidelines on chronic pain management and where there is no psychological contraindication, drug seeking behaviour or history of drug misuse.